<DOC>
	<DOC>NCT02836054</DOC>
	<brief_summary>Analysis of 4 CSF Alzheimer's disease biomarkers (total and phosphorylated tau protein, Aß40 and Aß1-42) and morphological brain MRI in older patients (&gt;60 year's old) with bipolar disorder, after an evaluation of their cognitive functions. Comparison between two groups of patients : patients with cognitive disorders and patients without cognitive disorders. The objective is to describe and compare the profile of those biomarkers in those two populations.</brief_summary>
	<brief_title>Study of Degenerescence CSF Hallmarks in Older Bipolar Patients</brief_title>
	<detailed_description>Describe the profile of the 4 neurodegeneration's biomarkers of Alzheimer's disease dosed in the cerebrospinal fluid (Total Tau proteins, phosphorylated, Aß40 and Aß1-42) for old subjects suffering from bipolar disorder with or without cognitive impairment.</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>male or female between 60 and 80 frenchspeaking, reading and writing patient affiliation to the French Social Security written informed consent obtained from the patient agree to undergo a lumbar puncture easy accessibility for the lumbar puncture Mini Mental State Examination (MMSE) &gt; 20 bipolar patients : type I or II state of euthymia for at least 4 weeks stable psychotropic drug treatment for at least 8 weeks no electroconvulsive therapy during the 6 months before inclusion distribution in the "with cognitive disorder" or "without cognitive disorder" group is function of the result of the neuropsychological evaluation Noninclusion Criteria : severe visual or auditory disorder advanced lumbar osteoarthritis history of severe head injury, neurological disorders, diagnosed dementia addiction weaned for less than 12 months forced hospitalization in psychiatry MRI contraindications LP contraindications at least one of the outcome measures can't be performed : MRI LP : anticoagulation, bad accessibility</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>biomarkers</keyword>
	<keyword>CSF</keyword>
	<keyword>MRI</keyword>
	<keyword>Alzheimer's disease</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>cognitive functions</keyword>
</DOC>